A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial

Key summary points Aim Describes the incidence and prevalence of DDIs and the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Findings DDI prevalence was high and associated with incident ADRs. Higher prevalence of new onset falls, major constipation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European geriatric medicine 2024-10, Vol.15 (5), p.1357-1367
Hauptverfasser: Simal, Ine, Somers, Annemie, Amrouch, Cheima, Capiau, Andreas, Cherubini, Antonio, Cruz-Jentoft, Alfonso J., Gudmundsson, Adalsteinn, Soiza, Roy L., O.’Mahony, Denis, Petrovic, Mirko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1367
container_issue 5
container_start_page 1357
container_title European geriatric medicine
container_volume 15
creator Simal, Ine
Somers, Annemie
Amrouch, Cheima
Capiau, Andreas
Cherubini, Antonio
Cruz-Jentoft, Alfonso J.
Gudmundsson, Adalsteinn
Soiza, Roy L.
O.’Mahony, Denis
Petrovic, Mirko
description Key summary points Aim Describes the incidence and prevalence of DDIs and the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Findings DDI prevalence was high and associated with incident ADRs. Higher prevalence of new onset falls, major constipation, and major serum electrolyte disturbances was observed in patients with related and thus potentially causal DDIs. Message Clinicians should be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in multimorbid older inpatients. Purpose Drug-drug interactions (DDIs) are prevalent among multimorbid and polymedicated older adults and can increase the risk of adverse drug reactions (ADRs), hospital admissions, and mortality. This study describes the incidence and prevalence of 66 clinically relevant DDIs and analyses the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Methods The sub-study of the SENATOR trial that involved 1537 multimorbid older inpatients, recruited from 2016 to 2018 in six academic teaching hospitals in Belgium, Iceland, Ireland, Italy, Scotland, and Spain respectively, and analysed 66 potentially clinically significant DDIs. Descriptive analysis determined DDI and corresponding ADR prevalence/incidence. Results At baseline (median age: 78 [72, 84], 52.8% male), the prevalence of patients with DDIs was high (50.9%), increased during hospitalisation (55.2%) and reduced to 49.7% after 12 weeks. The most common DDIs were: ≥ 2 potassium reducing drugs (17.1%), ≥ 3 centrally acting drugs (9.0%), and SSRI + loop/thiazide diuretic (7.2%). Of all participants, one-third experienced a prevalent (36.6%)/incident (35.8%) ADR. Major serum electrolyte disturbance had the highest incidence (10.7%)/prevalence (11.5%). Incident ADRs were more common in patients with DDIs (p = 0.013). A higher prevalence of new onset falls (p = 0.013), major constipation (p = 0.004), and major serum electrolyte disturbances (p = 0.006) was observed in patients with related and thus potentially causal DDIs. Conclusions Clinicians should, be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in older multimorbid inpatients. Regularly reevaluating the appropriateness of the frequently prescribed drug classes and initiating judicious deprescribing is recommended.
doi_str_mv 10.1007/s41999-024-01025-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3087563237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3087563237</sourcerecordid><originalsourceid>FETCH-LOGICAL-c228t-cde747cfcaa1d8aa9e52fd2f917dd6a9a6f6d3476e36438936a6b8b96584c4e93</originalsourceid><addsrcrecordid>eNp9kc1u1DAURiMEolXpC7BAXrIJdWzHP-xGVYFKFZWgrC2PfT24SuLg61Tqq_C0ZGbaLvHi2vI937c5TfO-o586StUFis4Y01ImWtpR1rfqVXPaaaVbJXv1-uUtzElzjnhP18OZMUq8bU64oaaXmp02fzckAPqS5poegLjJDY-YkORIQll27X6QNFUozteUJ1yRQHwuBXDOU0jTjrjwAAXhECAFnsE0kXEZahpz2aZA8hCgrJ-zqwmmip9JTIc8kljySOpvID-vvm_ubn-QWpIb3jVvohsQzp_us-bXl6u7y2_tze3X68vNTesZ07X1AZRQPnrnuqCdM9CzGFg0nQpBOuNklIELJYFLwbXh0smt3hrZa-EFGH7WfDz2ziX_WQCrHRN6GAY3QV7QcqpVLznjakXZEfUlIxaIdi5pdOXRdtTutdijFrtqsQctdh_68NS_bEcIL5FnCSvAjwCuq2kHxd7npawm8H-1_wARLpwx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3087563237</pqid></control><display><type>article</type><title>A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Simal, Ine ; Somers, Annemie ; Amrouch, Cheima ; Capiau, Andreas ; Cherubini, Antonio ; Cruz-Jentoft, Alfonso J. ; Gudmundsson, Adalsteinn ; Soiza, Roy L. ; O.’Mahony, Denis ; Petrovic, Mirko</creator><creatorcontrib>Simal, Ine ; Somers, Annemie ; Amrouch, Cheima ; Capiau, Andreas ; Cherubini, Antonio ; Cruz-Jentoft, Alfonso J. ; Gudmundsson, Adalsteinn ; Soiza, Roy L. ; O.’Mahony, Denis ; Petrovic, Mirko</creatorcontrib><description>Key summary points Aim Describes the incidence and prevalence of DDIs and the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Findings DDI prevalence was high and associated with incident ADRs. Higher prevalence of new onset falls, major constipation, and major serum electrolyte disturbances was observed in patients with related and thus potentially causal DDIs. Message Clinicians should be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in multimorbid older inpatients. Purpose Drug-drug interactions (DDIs) are prevalent among multimorbid and polymedicated older adults and can increase the risk of adverse drug reactions (ADRs), hospital admissions, and mortality. This study describes the incidence and prevalence of 66 clinically relevant DDIs and analyses the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Methods The sub-study of the SENATOR trial that involved 1537 multimorbid older inpatients, recruited from 2016 to 2018 in six academic teaching hospitals in Belgium, Iceland, Ireland, Italy, Scotland, and Spain respectively, and analysed 66 potentially clinically significant DDIs. Descriptive analysis determined DDI and corresponding ADR prevalence/incidence. Results At baseline (median age: 78 [72, 84], 52.8% male), the prevalence of patients with DDIs was high (50.9%), increased during hospitalisation (55.2%) and reduced to 49.7% after 12 weeks. The most common DDIs were: ≥ 2 potassium reducing drugs (17.1%), ≥ 3 centrally acting drugs (9.0%), and SSRI + loop/thiazide diuretic (7.2%). Of all participants, one-third experienced a prevalent (36.6%)/incident (35.8%) ADR. Major serum electrolyte disturbance had the highest incidence (10.7%)/prevalence (11.5%). Incident ADRs were more common in patients with DDIs (p = 0.013). A higher prevalence of new onset falls (p = 0.013), major constipation (p = 0.004), and major serum electrolyte disturbances (p = 0.006) was observed in patients with related and thus potentially causal DDIs. Conclusions Clinicians should, be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in older multimorbid inpatients. Regularly reevaluating the appropriateness of the frequently prescribed drug classes and initiating judicious deprescribing is recommended.</description><identifier>ISSN: 1878-7649</identifier><identifier>ISSN: 1878-7657</identifier><identifier>EISSN: 1878-7657</identifier><identifier>DOI: 10.1007/s41999-024-01025-7</identifier><identifier>PMID: 39095682</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Aged ; Aged, 80 and over ; Drug Interactions ; Drug-Related Side Effects and Adverse Reactions - epidemiology ; Female ; Geriatrics/Gerontology ; Hospitalization - statistics &amp; numerical data ; Humans ; Incidence ; Inpatients - statistics &amp; numerical data ; Internal Medicine ; Male ; Medicine ; Medicine &amp; Public Health ; Multimorbidity ; Polypharmacy ; Prevalence ; Research Paper</subject><ispartof>European geriatric medicine, 2024-10, Vol.15 (5), p.1357-1367</ispartof><rights>The Author(s), under exclusive licence to European Geriatric Medicine Society 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to European Geriatric Medicine Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c228t-cde747cfcaa1d8aa9e52fd2f917dd6a9a6f6d3476e36438936a6b8b96584c4e93</cites><orcidid>0000-0002-7506-8646 ; 0009-0007-3163-4785 ; 0000-0003-2458-5237 ; 0000-0001-9245-4154 ; 0009-0007-9570-2433 ; 0000-0002-1397-4272 ; 0000-0001-6708-7372 ; 0000-0003-2236-5222 ; 0000-0001-7628-4861</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s41999-024-01025-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s41999-024-01025-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39095682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Simal, Ine</creatorcontrib><creatorcontrib>Somers, Annemie</creatorcontrib><creatorcontrib>Amrouch, Cheima</creatorcontrib><creatorcontrib>Capiau, Andreas</creatorcontrib><creatorcontrib>Cherubini, Antonio</creatorcontrib><creatorcontrib>Cruz-Jentoft, Alfonso J.</creatorcontrib><creatorcontrib>Gudmundsson, Adalsteinn</creatorcontrib><creatorcontrib>Soiza, Roy L.</creatorcontrib><creatorcontrib>O.’Mahony, Denis</creatorcontrib><creatorcontrib>Petrovic, Mirko</creatorcontrib><title>A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial</title><title>European geriatric medicine</title><addtitle>Eur Geriatr Med</addtitle><addtitle>Eur Geriatr Med</addtitle><description>Key summary points Aim Describes the incidence and prevalence of DDIs and the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Findings DDI prevalence was high and associated with incident ADRs. Higher prevalence of new onset falls, major constipation, and major serum electrolyte disturbances was observed in patients with related and thus potentially causal DDIs. Message Clinicians should be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in multimorbid older inpatients. Purpose Drug-drug interactions (DDIs) are prevalent among multimorbid and polymedicated older adults and can increase the risk of adverse drug reactions (ADRs), hospital admissions, and mortality. This study describes the incidence and prevalence of 66 clinically relevant DDIs and analyses the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Methods The sub-study of the SENATOR trial that involved 1537 multimorbid older inpatients, recruited from 2016 to 2018 in six academic teaching hospitals in Belgium, Iceland, Ireland, Italy, Scotland, and Spain respectively, and analysed 66 potentially clinically significant DDIs. Descriptive analysis determined DDI and corresponding ADR prevalence/incidence. Results At baseline (median age: 78 [72, 84], 52.8% male), the prevalence of patients with DDIs was high (50.9%), increased during hospitalisation (55.2%) and reduced to 49.7% after 12 weeks. The most common DDIs were: ≥ 2 potassium reducing drugs (17.1%), ≥ 3 centrally acting drugs (9.0%), and SSRI + loop/thiazide diuretic (7.2%). Of all participants, one-third experienced a prevalent (36.6%)/incident (35.8%) ADR. Major serum electrolyte disturbance had the highest incidence (10.7%)/prevalence (11.5%). Incident ADRs were more common in patients with DDIs (p = 0.013). A higher prevalence of new onset falls (p = 0.013), major constipation (p = 0.004), and major serum electrolyte disturbances (p = 0.006) was observed in patients with related and thus potentially causal DDIs. Conclusions Clinicians should, be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in older multimorbid inpatients. Regularly reevaluating the appropriateness of the frequently prescribed drug classes and initiating judicious deprescribing is recommended.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Drug Interactions</subject><subject>Drug-Related Side Effects and Adverse Reactions - epidemiology</subject><subject>Female</subject><subject>Geriatrics/Gerontology</subject><subject>Hospitalization - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Incidence</subject><subject>Inpatients - statistics &amp; numerical data</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Multimorbidity</subject><subject>Polypharmacy</subject><subject>Prevalence</subject><subject>Research Paper</subject><issn>1878-7649</issn><issn>1878-7657</issn><issn>1878-7657</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAURiMEolXpC7BAXrIJdWzHP-xGVYFKFZWgrC2PfT24SuLg61Tqq_C0ZGbaLvHi2vI937c5TfO-o586StUFis4Y01ImWtpR1rfqVXPaaaVbJXv1-uUtzElzjnhP18OZMUq8bU64oaaXmp02fzckAPqS5poegLjJDY-YkORIQll27X6QNFUozteUJ1yRQHwuBXDOU0jTjrjwAAXhECAFnsE0kXEZahpz2aZA8hCgrJ-zqwmmip9JTIc8kljySOpvID-vvm_ubn-QWpIb3jVvohsQzp_us-bXl6u7y2_tze3X68vNTesZ07X1AZRQPnrnuqCdM9CzGFg0nQpBOuNklIELJYFLwbXh0smt3hrZa-EFGH7WfDz2ziX_WQCrHRN6GAY3QV7QcqpVLznjakXZEfUlIxaIdi5pdOXRdtTutdijFrtqsQctdh_68NS_bEcIL5FnCSvAjwCuq2kHxd7npawm8H-1_wARLpwx</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Simal, Ine</creator><creator>Somers, Annemie</creator><creator>Amrouch, Cheima</creator><creator>Capiau, Andreas</creator><creator>Cherubini, Antonio</creator><creator>Cruz-Jentoft, Alfonso J.</creator><creator>Gudmundsson, Adalsteinn</creator><creator>Soiza, Roy L.</creator><creator>O.’Mahony, Denis</creator><creator>Petrovic, Mirko</creator><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7506-8646</orcidid><orcidid>https://orcid.org/0009-0007-3163-4785</orcidid><orcidid>https://orcid.org/0000-0003-2458-5237</orcidid><orcidid>https://orcid.org/0000-0001-9245-4154</orcidid><orcidid>https://orcid.org/0009-0007-9570-2433</orcidid><orcidid>https://orcid.org/0000-0002-1397-4272</orcidid><orcidid>https://orcid.org/0000-0001-6708-7372</orcidid><orcidid>https://orcid.org/0000-0003-2236-5222</orcidid><orcidid>https://orcid.org/0000-0001-7628-4861</orcidid></search><sort><creationdate>202410</creationdate><title>A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial</title><author>Simal, Ine ; Somers, Annemie ; Amrouch, Cheima ; Capiau, Andreas ; Cherubini, Antonio ; Cruz-Jentoft, Alfonso J. ; Gudmundsson, Adalsteinn ; Soiza, Roy L. ; O.’Mahony, Denis ; Petrovic, Mirko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c228t-cde747cfcaa1d8aa9e52fd2f917dd6a9a6f6d3476e36438936a6b8b96584c4e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Drug Interactions</topic><topic>Drug-Related Side Effects and Adverse Reactions - epidemiology</topic><topic>Female</topic><topic>Geriatrics/Gerontology</topic><topic>Hospitalization - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Incidence</topic><topic>Inpatients - statistics &amp; numerical data</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Multimorbidity</topic><topic>Polypharmacy</topic><topic>Prevalence</topic><topic>Research Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simal, Ine</creatorcontrib><creatorcontrib>Somers, Annemie</creatorcontrib><creatorcontrib>Amrouch, Cheima</creatorcontrib><creatorcontrib>Capiau, Andreas</creatorcontrib><creatorcontrib>Cherubini, Antonio</creatorcontrib><creatorcontrib>Cruz-Jentoft, Alfonso J.</creatorcontrib><creatorcontrib>Gudmundsson, Adalsteinn</creatorcontrib><creatorcontrib>Soiza, Roy L.</creatorcontrib><creatorcontrib>O.’Mahony, Denis</creatorcontrib><creatorcontrib>Petrovic, Mirko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European geriatric medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simal, Ine</au><au>Somers, Annemie</au><au>Amrouch, Cheima</au><au>Capiau, Andreas</au><au>Cherubini, Antonio</au><au>Cruz-Jentoft, Alfonso J.</au><au>Gudmundsson, Adalsteinn</au><au>Soiza, Roy L.</au><au>O.’Mahony, Denis</au><au>Petrovic, Mirko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial</atitle><jtitle>European geriatric medicine</jtitle><stitle>Eur Geriatr Med</stitle><addtitle>Eur Geriatr Med</addtitle><date>2024-10</date><risdate>2024</risdate><volume>15</volume><issue>5</issue><spage>1357</spage><epage>1367</epage><pages>1357-1367</pages><issn>1878-7649</issn><issn>1878-7657</issn><eissn>1878-7657</eissn><abstract>Key summary points Aim Describes the incidence and prevalence of DDIs and the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Findings DDI prevalence was high and associated with incident ADRs. Higher prevalence of new onset falls, major constipation, and major serum electrolyte disturbances was observed in patients with related and thus potentially causal DDIs. Message Clinicians should be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in multimorbid older inpatients. Purpose Drug-drug interactions (DDIs) are prevalent among multimorbid and polymedicated older adults and can increase the risk of adverse drug reactions (ADRs), hospital admissions, and mortality. This study describes the incidence and prevalence of 66 clinically relevant DDIs and analyses the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Methods The sub-study of the SENATOR trial that involved 1537 multimorbid older inpatients, recruited from 2016 to 2018 in six academic teaching hospitals in Belgium, Iceland, Ireland, Italy, Scotland, and Spain respectively, and analysed 66 potentially clinically significant DDIs. Descriptive analysis determined DDI and corresponding ADR prevalence/incidence. Results At baseline (median age: 78 [72, 84], 52.8% male), the prevalence of patients with DDIs was high (50.9%), increased during hospitalisation (55.2%) and reduced to 49.7% after 12 weeks. The most common DDIs were: ≥ 2 potassium reducing drugs (17.1%), ≥ 3 centrally acting drugs (9.0%), and SSRI + loop/thiazide diuretic (7.2%). Of all participants, one-third experienced a prevalent (36.6%)/incident (35.8%) ADR. Major serum electrolyte disturbance had the highest incidence (10.7%)/prevalence (11.5%). Incident ADRs were more common in patients with DDIs (p = 0.013). A higher prevalence of new onset falls (p = 0.013), major constipation (p = 0.004), and major serum electrolyte disturbances (p = 0.006) was observed in patients with related and thus potentially causal DDIs. Conclusions Clinicians should, be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in older multimorbid inpatients. Regularly reevaluating the appropriateness of the frequently prescribed drug classes and initiating judicious deprescribing is recommended.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>39095682</pmid><doi>10.1007/s41999-024-01025-7</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-7506-8646</orcidid><orcidid>https://orcid.org/0009-0007-3163-4785</orcidid><orcidid>https://orcid.org/0000-0003-2458-5237</orcidid><orcidid>https://orcid.org/0000-0001-9245-4154</orcidid><orcidid>https://orcid.org/0009-0007-9570-2433</orcidid><orcidid>https://orcid.org/0000-0002-1397-4272</orcidid><orcidid>https://orcid.org/0000-0001-6708-7372</orcidid><orcidid>https://orcid.org/0000-0003-2236-5222</orcidid><orcidid>https://orcid.org/0000-0001-7628-4861</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1878-7649
ispartof European geriatric medicine, 2024-10, Vol.15 (5), p.1357-1367
issn 1878-7649
1878-7657
1878-7657
language eng
recordid cdi_proquest_miscellaneous_3087563237
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Aged
Aged, 80 and over
Drug Interactions
Drug-Related Side Effects and Adverse Reactions - epidemiology
Female
Geriatrics/Gerontology
Hospitalization - statistics & numerical data
Humans
Incidence
Inpatients - statistics & numerical data
Internal Medicine
Male
Medicine
Medicine & Public Health
Multimorbidity
Polypharmacy
Prevalence
Research Paper
title A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T14%3A52%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20descriptive%20analysis%20of%20drug-drug%20interactions%20and%20corresponding%20adverse%20drug%20reactions%20in%20multimorbid%20older%20inpatients:%20findings%20from%20the%20SENATOR%20trial&rft.jtitle=European%20geriatric%20medicine&rft.au=Simal,%20Ine&rft.date=2024-10&rft.volume=15&rft.issue=5&rft.spage=1357&rft.epage=1367&rft.pages=1357-1367&rft.issn=1878-7649&rft.eissn=1878-7657&rft_id=info:doi/10.1007/s41999-024-01025-7&rft_dat=%3Cproquest_cross%3E3087563237%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3087563237&rft_id=info:pmid/39095682&rfr_iscdi=true